mesalamine has been researched along with eicosapentaenoic acid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Belluzzi, A; Daneshmend, TK; Everitt, SJ; Hawkey, CJ; Hawthorne, AB; Holmes, GK; Malkinson, C; Shaheen, MZ; Willars, JE | 1 |
| Hawkey, CJ; Hawthorne, AB; Mahida, YR | 1 |
| Kandula, M; Palanichamy, S; Rampal, A; Sunil Kumar, KB | 1 |
| Abbas, NAT; Abdelsameea, AA; Alabassery, N; Alsemeh, AE; Fawzy, A; Samy, W | 1 |
1 review(s) available for mesalamine and eicosapentaenoic acid
| Article | Year |
|---|---|
Therapeutic interventions in gastrointestinal disease based on an understanding of inflammatory mediators.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Cytokines; Eicosapentaenoic Acid; Fish Oils; Humans; Interleukins; Leukotriene B4; Mesalamine; Sulfasalazine | 1992 |
1 trial(s) available for mesalamine and eicosapentaenoic acid
| Article | Year |
|---|---|
Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Humans; Leukotriene B4; Male; Mesalamine; Middle Aged; Olive Oil; Plant Oils; Prednisolone; Prospective Studies; Remission Induction; Sulfasalazine | 1992 |
3 other study(ies) available for mesalamine and eicosapentaenoic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Discovery and preclinical development of a novel prodrug conjugate of mesalamine with eicosapentaenoic acid and caprylic acid for the treatment of inflammatory bowel diseases.
Topics: Aminosalicylic Acids; Animals; Caprylates; Colitis; Colon; Dextran Sulfate; Drug Discovery; Drug Evaluation, Preclinical; Eicosapentaenoic Acid; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Mice; Mice, Inbred C57BL; Prodrugs; Rats; Rats, Sprague-Dawley; Sulfasalazine | 2016 |
Icosapent ethyl alleviates acetic acid-induced ulcerative colitis via modulation of SIRT1 signaling pathway in rats.
Topics: Acetic Acid; Animals; Caspase 3; Colitis; Colitis, Ulcerative; Collagen; Colon; Eicosapentaenoic Acid; Male; Mesalamine; NF-E2-Related Factor 2; NF-kappa B; Rats; Rats, Wistar; Signal Transduction; Sirtuin 1; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53 | 2023 |